BRAF and neoplasm: The frequencies of RAS and BRAF mutations in mCRC tumor tissues or ctDNA are reported to be around 50% and 5–10%, respectively (Van Cutsem et al., 2016; Gong et al., 2017; Strickler et al., 2018).